ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Curtis G. Tribble
John A. Kern
Irving L. Kron
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mathias, M. A.
Right arrow Articles by Kron, I. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mathias, M. A.
Right arrow Articles by Kron, I. L.

Ann Thorac Surg 2000;70:1671-1674
© 2000 The Society of Thoracic Surgeons


Original articles: general thoracic

Aprotinin improves pulmonary function during reperfusion in an isolated lung model

Menen A. Mathias, MDa, Curtis G. Tribble, MDa, Jeffrey F. Dietz, BSa, Richard P. Nguyena, Kimberly S. Shockey, MSa, John A. Kern, MDa, Irving L. Kron, MDa

a Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Virginia Health Sciences Center, Charlottesville, Virginia, USA

Address reprint requests to Dr Kron, Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Virginia Health Sciences Center, Box 3111, MR4 Bldg, Charlottesville, VA 22908;
e-mail: ikron{at}virginia.edu

Presented at the Poster Session of the Thirty-sixth Annual Meeting of The Society of Thoracic Surgeons, Fort Lauderdale, FL, Jan 31–Feb 2, 2000.

Background. We hypothesized that the use of aprotinin would ameliorate the reperfusion injury observed after lung transplantation because of a reduction in the inflammatory response.

Methods. We used an isolated, whole blood-perfused, ventilated rabbit lung model to study the effects of aprotinin during reperfusion. The control animals (group A, n = 8) underwent lung harvest after pulmonary arterial prostaglandin E1 injection and Euro-Collins preservation flush before saline storage for 18 hours at 4°C. The experimental groups received either a low dose (3,000 KIU/mL; group B, n = 8) or a high dose (10,000 KIU/mL; group C, n = 8) of aprotinin added to the pulmonary flush before storage. Each lung was reperfused at 37°C at a rate of 60 mL/min.

Results. The arterial partial pressure of oxygen values of group B (low-dose aprotinin) were significantly higher than those of group A (control) after 10 minutes of reperfusion (69.19 ± 5.69 mm Hg versus 264.30 ± 48.59 mm Hg, respectively, p = 0.001). Similar results were recorded at 20 and at 30 minutes of reperfusion. Similarly, after 10 minutes of reperfusion, the differences between groups A and C were 69.19 ± 5.69 mm Hg versus 235.91 ± 28.63 mm Hg, respectively (p = 0.001).

Conclusions. The addition of aprotinin to the Euro-Collins pulmonary flush significantly improves arterial oxygenation in the early reperfusion period. The enhanced oxygenation suggests that aprotinin may offer protection against early reperfusion injury.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
M. D. McEvoy, S. T. Reeves, J. G. Reves, and F. G. Spinale
Aprotinin in Cardiac Surgery: A Review of Conventional and Novel Mechanisms of Action
Anesth. Analg., October 1, 2007; 105(4): 949 - 962.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
I. Inci, W. Zhai, S. Arni, S. Hillinger, P. Vogt, and W. Weder
N-Acetylcysteine Attenuates Lung Ischemia-Reperfusion Injury After Lung Transplantation
Ann. Thorac. Surg., July 1, 2007; 84(1): 240 - 246.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
H. B. Bittner, M. Richter, T. Kuntze, A. Rahmel, P. Dahlberg, M. Hertz, and F. W. Mohr
Aprotinin decreases reperfusion injury and allograft dysfunction in clinical lung transplantation
Eur. J. Cardiothorac. Surg., February 1, 2006; 29(2): 210 - 215.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
T. Shimoyama, N. Tabuchi, K. Kojima, H. Akamatsu, H. Arai, H. Tanaka, and M. Sunamori
Aprotinin attenuated ischemia-reperfusion injury in an isolated rat lung model after 18-hours preservation
Eur. J. Cardiothorac. Surg., October 1, 2005; 28(4): 581 - 587.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. A. Bull and J. Maurer
Aprotinin and preservation of myocardial function after ischemia-reperfusion injury
Ann. Thorac. Surg., February 1, 2003; 75(2): S735 - 739.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
S. Eren, H. Esme, A. E. Balci, O. Cakir, H. Buyukbayram, M. N. Eren, L. Erdinc, and O. Satici
The effect of aprotinin on ischemia-reperfusion injury in an in situ normothermic ischemic lung model
Eur. J. Cardiothorac. Surg., January 1, 2003; 23(1): 60 - 65.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
I. Inci, D. Inci, A. Dutly, A. Boehler, and W. Weder
Melatonin attenuates posttransplant lung ischemia-reperfusion injury
Ann. Thorac. Surg., January 1, 2002; 73(1): 220 - 225.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 by The Society of Thoracic Surgeons.